In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

Andrea Endimiani, Gopi Patel, Kristine M. Hujer, Mahesh Swaminathan, Federico Perez, Louis B. Rice, Michael R. Jacobs, Robert A. Bonomo

Research output: Contribution to journalArticlepeer-review

144 Scopus citations

Abstract

In vitro activity of fosfomycin was evaluated against 68 bla KPC-possessing Klebsiella pneumoniae (KpKPC) isolates, including 23 tigecycline- and/or colistin-nonsusceptible strains. By agar dilution, 93% of the overall KpKPC were susceptible (MIC50/90 of 16/64 μg/ml, respectively). The subgroup of 23 tigecycline- and/or colistin-nonsusceptible strains showed susceptibility rates of 87% (MIC50/90 of 32/128 μg/ml, respectively). Notably, 5 out of 6 extremely drug-resistant (tigecycline and colistin nonsusceptible) KpKPC were susceptible to fosfomycin. Compared to agar dilution, disk diffusion was more accurate than Etest.

Original languageEnglish
Pages (from-to)526-529
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Dive into the research topics of 'In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin'. Together they form a unique fingerprint.

Cite this